$ Value
$1.5M
Shares
197,182
Price
$8
Filed
Jan 20
Insider
Name
Cohen Joshua B
Title
Co-Chief Executive Officer
CIK
0001898644
Roles
Transaction Details
Transaction Date
2026-01-15
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
3,514,814
Footnotes
Reflects shares sold to cover option cost and tax obligations upon the option exercise pursuant to a preset sales plan adopted by the reporting person on November 12, 2025. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.26 to $13.76. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.82 to $13.835. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. | This option is fully vested and exercisable. The option is due to expire on February 19, 2026.
Filing Info
Cohen Joshua B's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-05 | AMLX | A | $0 |
| 2026-03-05 | AMLX | A | $0 |
| 2026-03-02 | AMLX | ▼ | $424K |
| 2026-02-02 | AMLX | ▼ | $228K |
| 2026-01-16 | AMLX | M | $21K |
| 2026-01-16 | AMLX | ▼ | $27K |
| 2026-01-16 | AMLX | M | $0 |
| 2026-01-15 | AMLX | M | $1.5M |
| 2026-01-15 | AMLX | ▼ | $1.9M |
| 2026-01-15 | AMLX | M | $0 |
Other Insiders at AMLX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
FRATES JAMES M
Chief Financial Officer
|
— | $167K | 2026-03-05 |
|
Bedrosian Camille L
Chief Medical Officer
|
— | $94K | 2026-03-05 |
|
Klee Justin B.
Co-Chief Executive Officer
|
— | $651K | 2026-03-05 |
|
Cohen Joshua B
Co-Chief Executive Officer
|
— | $652K | 2026-03-05 |
|
Mazzariello Gina
Chief Legal Officer
|
— | $198K | 2026-03-05 |